Search Results

There are 8000 results for: content related to: In vitro approaches to studying the metabolism of new psychoactive compounds

  1. Studies on the metabolism of the α-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC–MS and LC–high-resolution MS and its detectability in urine by GC–MS

    Journal of Mass Spectrometry

    Volume 45, Issue 12, December 2010, Pages: 1426–1442, Markus R. Meyer, Peng Du, Frank Schuster and Hans H. Maurer

    Version of Record online : 4 NOV 2010, DOI: 10.1002/jms.1859

  2. Development of a rapid LC-MS/MS method for direct urinalysis of designer drugs

    Drug Testing and Analysis

    Volume 3, Issue 7-8, July - August 2011, Pages: 496–504, Charlotte Bell, Claire George, Andrew T. Kicman and Allan Traynor

    Version of Record online : 11 JUL 2011, DOI: 10.1002/dta.306

  3. Identification of phase I and II metabolites of the new designer drug α-pyrrolidinohexiophenone (α-PHP) in human urine by liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QTOF-MS)

    Journal of Mass Spectrometry

    Volume 50, Issue 11, November 2015, Pages: 1305–1317, Michael Paul, Sergej Bleicher, Susanne Guber, Josef Ippisch, Aldo Polettini and Wolfgang Schultis

    Version of Record online : 13 OCT 2015, DOI: 10.1002/jms.3642

  4. Drugs of Abuse (Including Designer Drugs)

    Metabolism of Drugs and Other Xenobiotics

    Markus R. Meyer, Hans H. Maurer, Pages: 429–463, 2012

    Published Online : 4 JUN 2012, DOI: 10.1002/9783527630905.ch16

  5. Cathinone derivatives: A review of their chemistry, pharmacology and toxicology

    Drug Testing and Analysis

    Volume 3, Issue 7-8, July - August 2011, Pages: 439–453, John P. Kelly

    Version of Record online : 13 JUL 2011, DOI: 10.1002/dta.313

  6. Validation of the only commercially available immunoassay for synthetic cathinones in urine: Randox Drugs of Abuse V Biochip Array Technology

    Drug Testing and Analysis

    Volume 6, Issue 7-8, July-August 2014, Pages: 728–738, Kayla N. Ellefsen, Sébastien Anizan, Marisol S. Castaneto, Nathalie A. Desrosiers, Thomas M. Martin, Kevin L. Klette and Marilyn A. Huestis

    Version of Record online : 21 MAR 2014, DOI: 10.1002/dta.1633

  7. Identification of ten new designer drugs by GC-MS, UPLC-QTOF-MS, and NMR as part of a police investigation of a Danish Internet company

    Drug Testing and Analysis

    Volume 4, Issue 5, May 2012, Pages: 342–354, Lotte A. Reitzel, Petur W. Dalsgaard, Irene B. Müller and Claus Cornett

    Version of Record online : 18 NOV 2011, DOI: 10.1002/dta.358

  8. Changes in the prevalence of new psychoactive substances before and after the introduction of the generic scheduling of synthetic cannabinoids in Japan

    Drug Testing and Analysis

    Volume 6, Issue 7-8, July-August 2014, Pages: 832–839, Ruri Kikura-Hanajiri, Nahoko Uchiyama, Maiko Kawamura and Yukihiro Goda

    Version of Record online : 26 DEC 2013, DOI: 10.1002/dta.1584

  9. The in vivo and in vitro metabolism and the detectability in urine of 3’,4’-methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP), a new pyrrolidinophenone-type designer drug, studied by GC-MS and LC-MSn

    Drug Testing and Analysis

    Volume 6, Issue 7-8, July-August 2014, Pages: 746–756, Markus R. Meyer, Sandra Mauer, Golo M. J. Meyer, Julia Dinger, Birgit Klein, Folker Westphal and Hans H. Maurer

    Version of Record online : 7 OCT 2013, DOI: 10.1002/dta.1559

  10. Cross-reactivity of designer drugs, including cathinone derivatives, in commercial enzyme-linked immunosorbent assays

    Drug Testing and Analysis

    Volume 6, Issue 7-8, July-August 2014, Pages: 716–727, Madeleine J. Swortwood, W. Lee Hearn and Anthony P. DeCaprio

    Version of Record online : 15 MAY 2013, DOI: 10.1002/dta.1489

  11. Microbial biotransformation of five pyrrolidinophenone-type psychoactive substances in wastewater and a wastewater isolated Pseudomonas putida strain

    Drug Testing and Analysis

    Marie Mardal, Markus Bischoff, María Ibáñez, Ulla Ruffing, Félix Hernández and Markus R. Meyer

    Version of Record online : 4 APR 2017, DOI: 10.1002/dta.2165

  12. Psychoactive Phenethylamine, Piperazine, and Pyrrolidinophenone Derivatives

    Medical Toxicology of Drug Abuse: Synthesized Chemicals and Psychoactive Plants

    Brandon Wills, Timothy Erickson, Pages: 156–192, 2012

    Published Online : 2 FEB 2012, DOI: 10.1002/9781118105955.ch10

  13. You have free access to this content
    An analytical approach to the forensic identification of different classes of new psychoactive substances (NPSs) in seized materials

    Rapid Communications in Mass Spectrometry

    Volume 28, Issue 17, 15 September 2014, Pages: 1904–1916, Sabina Strano Rossi, Sara Odoardi, Adolfo Gregori, Giuseppe Peluso, Luigi Ripani, Giorgio Ortar, Giovanni Serpelloni and Francesco Saverio Romolo

    Version of Record online : 28 JUL 2014, DOI: 10.1002/rcm.6969

  14. Some new psychoactive substances: Precursor chemicals and synthesis-driven end-products

    Drug Testing and Analysis

    Volume 3, Issue 7-8, July - August 2011, Pages: 404–416, Michael Collins

    Version of Record online : 13 JUL 2011, DOI: 10.1002/dta.315

  15. Sensitive hydrophilic interaction liquid chromatography/tandem mass spectrometry method for rapid detection, quantification and confirmation of cathinone-derived designer drugs for doping control in equine plasma

    Rapid Communications in Mass Spectrometry

    Volume 28, Issue 2, 30 January 2014, Pages: 217–229, Xiaoqing Li, Cornelius E. Uboh, Lawrence R. Soma, Ying Liu, Fuyu Guan, Craig R. Aurand, David S. Bell, Youwen You, Jinwen Chen and George A. Maylin

    Version of Record online : 5 DEC 2013, DOI: 10.1002/rcm.6778

  16. Rapid screening of 35 new psychoactive substances by ion mobility spectrometry (IMS) and direct analysis in real time (DART) coupled to quadrupole time-of-flight mass spectrometry (QTOF-MS)

    Drug Testing and Analysis

    Volume 7, Issue 10, October 2015, Pages: 884–893, Seongshin Gwak and Jose R. Almirall

    Version of Record online : 18 MAR 2015, DOI: 10.1002/dta.1783

  17. Current awareness of piperazines: pharmacology and toxicology

    Drug Testing and Analysis

    Volume 3, Issue 7-8, July - August 2011, Pages: 430–438, Simon Elliott

    Version of Record online : 11 JUL 2011, DOI: 10.1002/dta.307

  18. You have free access to this content
    Mephedrone, Methylone and 3,4-Methylenedioxypyrovalerone (MDPV) Induce Conditioned Place Preference in Mice

    Basic & Clinical Pharmacology & Toxicology

    Volume 115, Issue 5, November 2014, Pages: 411–416, Louise Karlsson, Mikael Andersson, Robert Kronstrand and Fredrik C. Kugelberg

    Version of Record online : 6 MAY 2014, DOI: 10.1111/bcpt.12253

  19. New designer drug α-pyrrolidinovalerophenone (PVP): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques

    Journal of Mass Spectrometry

    Volume 44, Issue 6, June 2009, Pages: 952–964, Christoph Sauer, Frank T. Peters, Claudia Haas, Markus R. Meyer, Giselher Fritschi and Hans H. Maurer

    Version of Record online : 24 FEB 2009, DOI: 10.1002/jms.1571

  20. False-positive phencyclidine immunoassay results caused by 3,4-methylenedioxypyrovalerone (MDPV)

    Drug Testing and Analysis

    Volume 5, Issue 2, February 2013, Pages: 130–132, Abe M. Macher and Thomas M. Penders

    Version of Record online : 20 MAY 2012, DOI: 10.1002/dta.1371